Stockscreener 앱 받기
15.05
0.93%
0.125
전일 마감가:
$14.93
열려 있는:
$15.12
하루 거래량:
1.28M
Relative Volume:
0.23
시가총액:
$7.48B
수익:
$4.45B
순이익/손실:
$205.00M
주가수익비율:
37.64
EPS:
0.4
순현금흐름:
$372.00M
1주 성능:
+3.85%
1개월 성능:
+12.88%
6개월 성능:
+24.95%
1년 성능:
+13.64%
1일 변동 폭
$14.94
$15.18
1주일 범위
$14.61
$15.18
52주 변동 폭
$8.02
$15.78
엘란코 Stock (ELAN) Company Profile
명칭
Elanco Animal Health Inc
전화
877-352-6261
주소
2500 INNOVATION WAY, GREENFIELD
ELAN을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
ELAN
Elanco Animal Health Inc
|
15.05 | 7.26B | 4.45B | 205.00M | 372.00M | 0.40 |
|
ZTS
Zoetis Inc
|
152.84 | 68.05B | 9.29B | 2.52B | 2.28B | 5.57 |
|
TAK
Takeda Pharmaceutical Co Adr
|
14.77 | 46.58B | 30.08B | 710.16M | 4.45B | 0.2182 |
|
HLN
Haleon Plc Adr
|
9.745 | 43.71B | 14.35B | 1.85B | 0 | 0.4023 |
|
TEVA
Teva Pharmaceutical Industries Ltd Adr
|
16.58 | 18.40B | 16.54B | -1.64B | 749.00M | -1.45 |
|
UTHR
United Therapeutics Corp
|
303.88 | 13.23B | 2.99B | 1.21B | 1.13B | 25.06 |
엘란코 Stock (ELAN) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2025-07-17 | 업그레이드 | Leerink Partners | Market Perform → Outperform |
| 2025-06-26 | 업그레이드 | William Blair | Mkt Perform → Outperform |
| 2024-12-09 | 개시 | UBS | Buy |
| 2024-12-02 | 개시 | Leerink Partners | Market Perform |
| 2024-09-19 | 다운그레이드 | Morgan Stanley | Overweight → Equal-Weight |
| 2024-01-05 | 업그레이드 | Stifel | Hold → Buy |
| 2023-12-19 | 개시 | Jefferies | Buy |
| 2023-12-15 | 업그레이드 | Morgan Stanley | Equal-Weight → Overweight |
| 2023-12-07 | 개시 | Exane BNP Paribas | Outperform |
| 2023-04-20 | 업그레이드 | Barclays | Equal Weight → Overweight |
| 2022-08-18 | 다운그레이드 | Morgan Stanley | Overweight → Equal-Weight |
| 2022-08-16 | 다운그레이드 | JP Morgan | Overweight → Neutral |
| 2022-07-21 | 다운그레이드 | Goldman | Buy → Sell |
| 2022-07-12 | 개시 | Piper Sandler | Neutral |
| 2021-11-18 | 개시 | Morgan Stanley | Overweight |
| 2021-10-28 | 다운그레이드 | Stifel | Buy → Hold |
| 2021-08-05 | 재개 | Credit Suisse | Outperform |
| 2021-06-15 | 업그레이드 | Cleveland Research | Underperform → Neutral |
| 2021-05-11 | 업그레이드 | Barclays | Underweight → Equal Weight |
| 2021-05-11 | 업그레이드 | Gabelli & Co | Hold → Buy |
| 2021-04-15 | 개시 | Stifel | Buy |
| 2021-03-22 | 다운그레이드 | Gabelli & Co | Buy → Hold |
| 2021-02-26 | 업그레이드 | Credit Suisse | Neutral → Outperform |
| 2020-12-09 | 다운그레이드 | Argus | Buy → Hold |
| 2020-11-09 | 다운그레이드 | Barclays | Overweight → Underweight |
| 2020-08-20 | 업그레이드 | Morgan Stanley | Equal-Weight → Overweight |
| 2020-08-13 | 재개 | Credit Suisse | Neutral |
| 2020-08-04 | 재개 | Goldman | Buy |
| 2020-07-27 | 다운그레이드 | Cleveland Research | Neutral → Underperform |
| 2020-04-02 | 다운그레이드 | Morgan Stanley | Overweight → Equal-Weight |
| 2020-01-10 | 개시 | Raymond James | Mkt Perform |
| 2019-12-19 | 업그레이드 | BofA/Merrill | Neutral → Buy |
| 2019-11-07 | 업그레이드 | Morgan Stanley | Equal-Weight → Overweight |
| 2019-09-23 | 개시 | Barclays | Overweight |
| 2019-08-26 | 다운그레이드 | BofA/Merrill | Buy → Neutral |
| 2019-08-15 | 업그레이드 | UBS | Sell → Neutral |
| 2019-05-23 | 개시 | Guggenheim | Neutral |
| 2019-03-18 | 업그레이드 | BofA/Merrill | Neutral → Buy |
| 2019-03-13 | 재개 | Morgan Stanley | Equal-Weight |
| 2019-02-12 | 개시 | William Blair | Mkt Perform |
| 2019-01-23 | 개시 | UBS | Sell |
| 2019-01-15 | 개시 | Argus | Buy |
| 2018-10-15 | 개시 | Morgan Stanley | Equal-Weight |
모두보기
엘란코 주식(ELAN)의 최신 뉴스
Autogenous Vaccine for Aquaculture Market Generated - openPR.com
Elanco Animal Health Incorporated Stock Analysis and ForecastFree Predictions - jammulinksnews.com
Is Elanco Animal Health Incorporated a good long term investmentHigh-profit trading signals - jammulinksnews.com
What drives Elanco Animal Health Incorporated stock priceExplosive portfolio gains - jammulinksnews.com
What analysts say about Elanco Animal Health Incorporated stockMassive portfolio appreciation - jammulinksnews.com
Veterinary Oncology Market Growth in Future Scope 2025-2032 | - openPR.com
Veterinary DermatologyCompany Evaluation Report 2025 | Zoetis, Elanco, and Boehringer Ingelheim Dominate with Global Reach, Innovative Portfolios, and Strategic Expansion - Yahoo Finance
Leerink Partnrs Has Strong Estimate for ELAN FY2027 Earnings - Defense World
Xponance Inc. Has $256,000 Stock Holdings in Elanco Animal Health Incorporated (NYSE:ELAN) - Defense World
M&T Bank Corp Sells 1,445 Shares of Elanco Animal Health Incorporated (NYSE:ELAN) - Defense World
FY2025 Earnings Forecast for ELAN Issued By Leerink Partnrs - Defense World
Elanco Animal Health (NYSE:ELAN) Raised to “Outperform” at Leerink Partners - Defense World
Elanco Animal Health (ELAN) Soars 1.34% on Upgrade - AInvest
Bank of New York Mellon Corp Sells 47,745 Shares of Elanco Animal Health Incorporated (NYSE:ELAN) - Defense World
Leerink upgrades Elanco on pet health momentum, downgrades Zoetis By Investing.com - Investing.com Canada
Elanco Animal Health Inc (ELAN) Stock: A 52-Week Tale of Drops and Gains - investchronicle.com
This Mondelez International Analyst Turns Bullish; Here Are Top 5 Upgrades For Thursday - Benzinga
Leerink Partners upgrades Elanco Animal Health stock rating to Outperform By Investing.com - Investing.com Canada
Elanco (ELAN) Upgraded on Promising Pet Health Launches and Grow - GuruFocus
Elanco launches cattle respiratory vaccine - Beef Magazine
BiomEdit raises $18.4m Series B to expand designer probiotics platform - AgFunderNews
Are Options Traders Betting on a Big Move in ELAN Stock? - TradingView
Elanco Confirms Date and Conference Call for Second Quarter 2025 Financial Results Announcement - ETX View
Elanco's dog flu vaccine gets USDA nod - MSN
Neurizon, Elanco sign deal to advance ALS therapy NUZ-001 - ALS News Today
Elanco gets US Agriculture department nod for TruCan (ELAN:NYSE) - Seeking Alpha
USDA Approves Elanco's New Vaccine for Canine Influenza - MarketScreener
Elanco receives USDA nod for Trucan Ultra Civ canine flu vaccine - MarketScreener
Elanco Receives USDA Approval for TruCan™ Ultra CIV H3N2/H3N8 (Canine Influenza Vaccine) Bringing to Market a High Standard of Respiratory Protection - PR Newswire
Elanco Animal Health (ELAN) Shares Soar 1.94% Amid KBC Group NV Stake Reduction - AInvest
Levi & Korsinsky Notifies Elanco Animal Health Incorporated Investors of a Class Action Lawsuit and Upcoming DeadlineELAN - ACCESS Newswire
Shareholder Alert: Johnson Fistel, LLP Investigates Elanco Animal Health, Masimo, Fidelity National Information, and Super Micro Computer —Long-Term Investors are Encouraged to Contact the Firm - GlobeNewswire
Neurizon Enters into Global License with Elanco to Accelerate Commercialisation of NUZ-001 - Nasdaq
The Analyst Verdict: Elanco Animal Health In The Eyes Of 4 Experts - Benzinga
5 Revealing Analyst Questions From Elanco’s Q1 Earnings Call - Yahoo Finance
Duff & Phelps Provided a Fairness Opinion to Elanco in Connection with its Agreement to Acquire Bayer's Animal Health Business - Kroll
Elanco Releases 2024 Impact Report and Introduces New Framework - ACCESS Newswire
Elanco Animal Health (ELAN) Stock Rating Upgraded by William Blair | ELAN Stock News - GuruFocus
Elanco Animal Health: A Catalyst-Driven Revaluation in Agri-Sciences - AInvest
Elanco Animal Health Amends Receivables Loan Agreement - TipRanks
Shareholders in Elanco Animal Health (NYSE:ELAN) have lost 37%, as stock drops 3.5% this past week - Yahoo Finance
Zoetis Stock Is Falling. Why the Animal-Health Company Was Downgraded. - Barron's
Elanco (ELAN) Gains Attention Amid Competitive Market Shifts | E - GuruFocus
United States Veterinary Pain Management Market Size, Share & - openPR.com
Harbor Capital Advisors Inc. Has $9.41 Million Stock Position in Elanco Animal Health Incorporated (NYSE:ELAN) - MarketBeat
Elanco Receives Positive Opinion on Zenrelia (ilunocitinib) from - GuruFocus
Elanco (ELAN) Awaits European Approval for Zenrelia in Dogs - GuruFocus
엘란코 (ELAN) 재무 분석
매출
순이익
현금흐름
주당 순 이익
1.09%
자본화:
|
볼륨(24시간):